01 August 2007
Evaluation of analytic and motion-resistant performance of the Mindray 9006 Pulse Oximeter
Liming Peng, Cunliang Yan, Hong Lu, Yong XiaMed Sci Monit 2007; 13(8): MT19-27 :: ID: 491814
Abstract
Background: The Mindray 9006 is a newly developed pulse oximeter. The performance of noninvasive monitoring of arterial oxygen saturation by pulse oximetry (SpO[sub]2[/sub]) and pulse rate (PR) with the Mindray 9006 was evaluated.
Material/Methods: Twenty healthy volunteers participated in this study. The Mindray 9006 was evaluated according to guidelines including HS3-A, EP5-A, and EP9-A2 published by the CLSI, and ISO 9919. A blinded side-by-side comparison of the Mindray 9006 and the Masimo MS-3 oximeter was also performed.
Results:The results demonstrated that the coefficients of variation (CV) of imprecision were less than 1% for SpO[sub]2[/sub] and less than 5% for PR analyzed by the Mindray 9006. Comparisons of methods showed there was no significant difference in SpO[sub]2[/sub]/PR analysis between the Mindray 9006 with Rapidlab 855 CO-oxymeter or 812 Electrocardiogram (ECG) monitor (p>0.05) and between the Mindray 9006 and Masimo MS-3 (p>0.05). There was good correlation for SpO[sub]2[/sub] between the Mindray 9006 and CO-oxymetry or the Masimo MS-3 (r>0.96) and for PR between the Mindray 9006 and ECG or the Masimo MS-3 (r>0.98). The accuracy as the root-mean-square (A[sub]rms[/sub]) was less than 3% for both SpO[sub]2[/sub] and PR between the Mindray 9006 and CO-oxymetry or between the Mindray 9006 and ECG. Also, there was no significant difference for SpO[sub]2[/sub]/PR between the motion and rest conditions (p>0.05).
Conclusions:The overall performance of the Mindray 9006 for SpO[sub]2[/sub] and PR analysis is excellent and compares favorably with the Masimo MS-3.
Keywords: Adolescent, Oxygen - metabolism, Oximetry - methods, Movement, Models, Statistical, Heart Rate, Evaluation Studies as Topic, Equipment Design, Blood Gas Analysis, Blood Gas Analysis, Oxygen - metabolism, Oximetry - methods, Movement, Models, Statistical, Heart Rate, Evaluation Studies as Topic, Equipment Design, Adolescent
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952